secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75417 grounded facts newest July 15, 2026, 5:08 PM ET RSS · JSON

Showing 6201–6250 of 18417

Departed

Brian McFadden

Chief Executive Officer
ORBS · Eightco Holdings Inc.
Effective
2023-12-31
Successor
Kevin O'Donnell
Filed
February 26, 2024, 6:59 PM ET
Mr. McFadden’s resignation as Chief Executive Officer of the Company, effective as of December 31, 2023
Departed

Timothy Pitoniak

Chief Financial Officer
ACCS · ACCESS Newswire Inc.
Effective
2024-03-08
Successor
Steve Knerr
Filed
February 26, 2024, 6:59 PM ET
On February 20, 2024, Timothy Pitoniak informed Issuer Direct Corporation (the “ Company ”) of his resignation as Chief Financial Officer of the Company, effective March 8, 2024 (the “ Effective Date” ).
Appointed (interim)

Steve Knerr

interim Principal Accounting Officer and interim Chief Financial Officer
ACCS · ACCESS Newswire Inc.
Filed
February 26, 2024, 6:59 PM ET
the Board intends to appoint Steve Knerr, the Company’s current Vice President of Finance and Controller, as its interim Principal Accounting Officer and interim Chief Financial Officer.
Appointed (interim)

Eric Mosser

President and Interim Chief Executive Officer
KAVL · Kaival Brands Innovations Group, Inc.
Effective
2024-02-23
Filed
February 26, 2024, 6:59 PM ET
On February 23, 2024, the Board appointed Eric Mosser, a current Senior Advisor to the Company and the Chief Executive Officer of Kaival International Brands, LLC, a wholly owned subsidiary of the Company, as the Company’s President and Interim Chief Executive Officer, to serve in such capacity until a successor is duly appointed and approved by the Board.
Departed (interim)

Barry M. Hopkins

Interim Chief Executive Officer
KAVL · Kaival Brands Innovations Group, Inc.
Effective
2024-02-22
Successor
Eric Mosser
Filed
February 26, 2024, 6:59 PM ET
On February 22, 2024, Barry M. Hopkins, the Interim Chief Executive Officer, President, and Director of the Company, provided written notice to the Company’s Board of Directors (the “Board”) of his resignation, effectively immediately.
Departed

Thomas Metzler

Chief Financial Officer
KAVL · Kaival Brands Innovations Group, Inc.
Effective
2024-02-20
Filed
February 26, 2024, 6:59 PM ET
On February 20, 2024, Thomas Metzler, the Chief Financial Officer, Secretary and Treasurer of the Company, provided written notice to the Company’s Board of his resignation, effectively immediately.
Departed

Amir Aghdaei

President and Chief Executive Officer
NVST · Envista Holdings Corp
Filed
February 26, 2024, 6:59 PM ET
On February 22, 2024, Envista Holdings Corporation (the “Company”) and Amir Aghdaei, the President and Chief Executive Officer of the Company, entered into a transition letter agreement (the “Transition Agreement”), setting forth the terms of Mr. Aghdaei’s anticipated transition from his position as the Company’s President and Chief Executive Officer.
Appointed

R. Ryan Richards

Executive Vice President and Chief Financial Officer of the Company
ZION · ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Effective
2024-04-01
Filed
February 23, 2024, 6:59 PM ET
R. Ryan Richards will succeed Mr. Burdiss as Executive Vice President and Chief Financial Officer of the Company, having previously served as the Company’s Senior Vice President and Corporate Controller since 2021.
Appointed

Jackson Hsieh

Chief Executive Officer and President
MAC · MACERICH CO
Effective
2024-03-01
Filed
February 23, 2024, 6:59 PM ET
unanimously appointed Jackson Hsieh to fill the newly created vacancy, effective concurrently with his appointment to the role of Chief Executive Officer and President on March 1, 2024.
Appointed (interim)

Forrest Hoffmaster

interim Chief Executive Officer
Medicine Man Technologies, Inc.
Effective
2024-02-21
Filed
February 23, 2024, 6:59 PM ET
On February 21, 2024 (“Appointment Date”), the Board appointed Forrest Hoffmaster, the Company’s Chief Financial Officer, as interim Chief Executive Officer of the Company.
Departed

Nirup Krishnamurthy

Chief Executive Officer
Medicine Man Technologies, Inc.
Effective
2024-02-20
Successor
Forrest Hoffmaster
Filed
February 23, 2024, 6:59 PM ET
On February 20, 2024, the Company received notice of the resignation of Nirup Krishnamurthy as a member of the Company’s board of directors (the “Board”) and Chief Executive Officer of the Company
Appointed

Craig Hopkins

Chief Executive Officer and President
BRN · BARNWELL INDUSTRIES INC
Effective
2024-04-01
Filed
February 23, 2024, 6:59 PM ET
Mr. Craig Hopkins would become the Chief Executive Officer and President of the Company.
Appointed

Kimberly A. Fields

President and Chief Executive Officer
ATI · ATI INC
Effective
2024-07-01
Filed
February 23, 2024, 6:59 PM ET
appointed Kimberly A. Fields, currently the Company’s President and Chief Operating Officer, to serve as President and Chief Executive Officer of the Company, effective as of July 1, 2024.
Departed

Stephen T. Wills

Chief Financial Officer
Cactus Acquisition Corp. 1 Ltd
Effective
2024-02-23
Filed
February 23, 2024, 6:59 PM ET
the following officers submitted the resignation of their respective offices: Ofer Gonen as Chief Executive Officer, and Stephen T. Wills as Chief Financial Officer.
Departed

Ofer Gonen

Chief Executive Officer
Cactus Acquisition Corp. 1 Ltd
Effective
2024-02-23
Filed
February 23, 2024, 6:59 PM ET
the following officers submitted the resignation of their respective offices: Ofer Gonen as Chief Executive Officer, and Stephen T. Wills as Chief Financial Officer.
Role change

Jason Dubinsky

principal accounting officer (in addition to Chief Financial Officer)
MORN · Morningstar, Inc.
Effective
2024-02-23
Filed
February 23, 2024, 6:59 PM ET
the Company designated Jason Dubinsky (age 50) as principal accounting officer, in addition to his current role as Chief Financial Officer (and principal financial officer) of the Company.
Departed

Charles Scheiwe

Chief Financial Officer and Secretary
FLUX · Flux Power Holdings, Inc.
Effective
2024-03-01
Successor
Kevin S. Royal
Filed
February 23, 2024, 6:59 PM ET
On February 16, 2024, the Company and Mr. Charles Scheiwe agreed to the stepping down of Mr. Scheiwe as the Company’s Chief Financial Officer and Secretary, including all positions with the Company and Flux Power, Inc., a wholly-owned subsidiary of the Company (“Flux”) and transitioning to a consultant for the Company (“the “Transition”), effective March 1, 2024 (the “Separation Date”).
Appointed

Kevin S. Royal

Chief Financial Officer and Corporate Secretary
FLUX · Flux Power Holdings, Inc.
Effective
2024-03-04
Filed
February 23, 2024, 6:59 PM ET
On February 22, 2024, as a result of Mr. Scheiwe’s stepping down in connection with the Transition, the Board appointed Mr. Kevin S. Royal as Chief Financial Officer and Corporate Secretary, to be effective March 4, 2024.
Departed

Richard A. Fair

President and Chief Executive Officer
BELLICUM PHARMACEUTICALS, INC
Effective
2024-02-23
Successor
Dave Maggio
Filed
February 23, 2024, 6:59 PM ET
Mr. Richard A. Fair resigned as President and Chief Executive Officer of the Company
Appointed

Dave Maggio

Chief Executive Officer
BELLICUM PHARMACEUTICALS, INC
Effective
2024-02-23
Filed
February 23, 2024, 6:59 PM ET
the Board appointed Dave Maggio to the position of Chief Executive Officer
Departed

Christopher Meyer

Chief Financial Officer
BLMN · Bloomin' Brands, Inc.
Filed
February 23, 2024, 6:59 PM ET
On February 20, 2024, Christopher Meyer, the Company’s Chief Financial Officer notified the Company of his intention to retire from the Company in 2024.
Departed

David P. Singelyn

Chief Executive Officer
AMH · American Homes 4 Rent
Effective
2024-12-31
Successor
Bryan Smith
Filed
February 23, 2024, 6:59 PM ET
On February 22, 2024, American Homes 4 Rent (the “Company”) announced that David P. Singelyn, the Company’s Chief Executive Officer, had notified the Board of Trustees (the “Board”) of the Company of his intent to retire.
Appointed

Bryan Smith

Chief Executive Officer
AMH · American Homes 4 Rent
Effective
2025-01-01
Filed
February 23, 2024, 6:59 PM ET
the Board had appointed Bryan Smith, the Company’s Chief Operating Officer, as the new Chief Executive Officer of the Company, effective upon Mr. Singelyn’s retirement
Role change

David J. Arthur

President and Chief Executive Officer
DCOY · Decoy Therapeutics Inc.
Effective
2024-02-20
Filed
February 23, 2024, 6:59 PM ET
On February 20, 2024 (the “Separation Date”), Salarius Pharmaceuticals, Inc. (the “Company”) entered into a separation and release agreement (the “Separation Agreement”) with David J. Arthur, the Company’s President and Chief Executive Officer, which provides for Mr. Arthur’s separation of employment, effective as of the Separation Date.
Appointed (interim)

Mr. Forelle

interim consulting CEO
First Capital Real Estate Trust Inc
Effective
2020-07-01
Filed
February 23, 2024, 6:59 PM ET
In July 2020, Mr. Forelle was appointed interim consulting CEO reporting to the board.
Role change

P. Cameron Hyzer

Chief Financial Officer and Principal Accounting Officer
GTM · ZoomInfo Technologies Inc.
Effective
2024-02-26
Filed
February 23, 2024, 6:59 PM ET
Effective February 26, 2024, P. Cameron Hyzer, who has served as ZoomInfo’s Chief Financial Officer since 2018, will assume the additional role of principal accounting officer.
Departed

Mark W. Smith

Senior Vice President and Chief Financial Officer
HP · Helmerich & Payne, Inc.
Effective
2024-08-15
Filed
February 22, 2024, 6:59 PM ET
On February 19, 2024, Mark W. Smith informed Helmerich & Payne, Inc. (the “Company”) that he will retire from his position as Senior Vice President and Chief Financial Officer of the Company effective August 15, 2024 or such earlier date as agreed to with the Company (the “Transition Date”).
Departed

Nishan J. Vartanian

Chief Executive Officer
MSA · MSA Safety Inc
Effective
2024-05-10
Successor
Steven C. Blanco
Filed
February 22, 2024, 6:59 PM ET
Nishan J. Vartanian’s announcement to the Board on February 21, 2024, of his intention to retire as Chief Executive Officer in May 2024.
Appointed

Steven C. Blanco

Chief Executive Officer
MSA · MSA Safety Inc
Effective
2024-05-10
Filed
February 22, 2024, 6:59 PM ET
On February 21, 2024, the Board of Directors (the “Board”) of MSA Safety Incorporated (the “Company”) elected Steven C. Blanco as Chief Executive Officer, to be effective May 10, 2024.
Departed

C. Evan Ballantyne

Chief Financial Officer
GANX · Gain Therapeutics, Inc.
Effective
2024-03-01
Filed
February 22, 2024, 6:59 PM ET
On February 19, 2024, Gain Therapeutics, Inc. (the “Company”) received notice of the resignation of C. Evan Ballantyne as the Company’s Chief Financial Officer, and all other positions held at the Company, to be effective March 1, 2024.
Departed

Nick Bailey

President and CEO of RE/MAX
RMAX · RE/MAX Holdings, Inc.
Effective
2024-02-22
Successor
Amy Lessinger
Filed
February 22, 2024, 6:59 PM ET
Ms. Lessinger succeeds Nick Bailey, President and CEO of RE/MAX, who is leaving RE/MAX and the Company.
Departed

Michael Ellis

Chief Financial Officer
FLYW · Flywire Corp
Effective
2024-03-04
Successor
Cosmin Pitigoi
Filed
February 22, 2024, 6:59 PM ET
As of the Effective Date, Mr. Pitigoi will be replacing Michael Ellis as the Chief Financial Officer of Flywire.
Appointed

Cosmin Pitigoi

Chief Financial Officer
FLYW · Flywire Corp
Effective
2024-03-04
Filed
February 22, 2024, 6:59 PM ET
On February 22, 2024, Flywire Corporation (“Flywire”) announced that Cosmin Pitigoi will join Flywire as Chief Financial Officer and as its principal financial and principal accounting officer, effective March 4, 2024
Departed

Robert Noreck

Chief Financial Officer
BRIGHTCOVE INC
Effective
2024-05-31
Filed
February 22, 2024, 6:59 PM ET
On February 21, 2024, Robert Noreck, the Company's Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer (collectively, “CFO”), notified the Company of his intent to resign as CFO, effective as of the earlier of May 31, 2024 and the appointment of a successor CFO (such date, the “Transition Date”).
Departed

Aoife Brennan

President and Chief Executive Officer
SYBX · SYNLOGIC, INC.
Effective
2024-03-09
Filed
February 22, 2024, 6:59 PM ET
Synlogic, Inc. (the “ Company ”) and Aoife Brennan, M.B., Ch.B., President and Chief Executive Officer, agreed that Dr. Brennan’s employment with the Company will terminate effective March 9, 2024
Appointed

Khairul Azmi Bin Ismaon

Chief Executive Officer
EVe Mobility Acquisition Corp
Filed
February 22, 2024, 6:59 PM ET
Khairul Azmi Bin Ismaon , age 41, serves as our Chief Executive Officer and one of our directors.
Appointed

Dr. Ulf Henning Richter

Chief Financial Officer
EVe Mobility Acquisition Corp
Filed
February 22, 2024, 6:59 PM ET
Dr. Ulf Henning Richter , age 44, serves as our Chief Financial Officer.
Appointed

Jian-Meng Yang

Chief Executive Officer
Arculus System Co., Ltd.
Filed
February 22, 2024, 6:59 PM ET
Jian-Meng Yang was appointed as Chief Executive Officer, Treasurer and Secretary, and Director of the Company.
Departed

Michael G. Rippey

Chief Executive Officer
SXC · SunCoke Energy, Inc.
Effective
2024-05-15
Successor
Katherine T. Gates
Filed
February 22, 2024, 6:59 PM ET
announced Michael G. Rippey's retirement as Chief Executive Officer (“ CEO ”) and his resignation from the Company's Board of Directors (the “ Board ”), effective May 15, 2024.
Appointed

Katherine T. Gates

Chief Executive Officer and President
SXC · SunCoke Energy, Inc.
Effective
2024-05-15
Filed
February 22, 2024, 6:59 PM ET
The Company also announced that current President, Katherine T. Gates, will succeed Mr. Rippey as CEO, effective upon his retirement.
Appointed

Jason Alger

Chief Financial Officer
HCAT · Health Catalyst, Inc.
Effective
2024-03-01
Filed
February 22, 2024, 6:59 PM ET
On February 22, 2024, the Company announced that Jason Alger, age 40, the Company’s Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.
Departed

Bryan Hunt

Chief Financial Officer
HCAT · Health Catalyst, Inc.
Effective
2024-03-01
Successor
Jason Alger
Filed
February 22, 2024, 6:59 PM ET
On February 16, 2024, Bryan Hunt informed the board of directors of the Company (the Board) of, and on February 20, 2024, the Board accepted, his resignation as the Company's Chief Financial Officer and principal financial officer, effective March 1, 2024.
Departed

Tom Fitzgerald

Chief Financial Officer
PLNT · Planet Fitness, Inc.
Effective
2024-09-01
Filed
February 22, 2024, 6:59 PM ET
Tom Fitzgerald notified the Company of his decision to retire as the Company’s Chief Financial Officer (“CFO”), effective as of September 1, 2024.
Departed

Tom Fitzgerald

Chief Financial Officer
PLNT · Planet Fitness, Inc.
Effective
2024-09-01
Filed
February 22, 2024, 6:59 PM ET
On February 19, 2024, Tom Fitzgerald notified the Company of his decision to retire as the Company’s Chief Financial Officer (“CFO”), effective as of September 1, 2024.
Role change

Gregory H. Trepp

Chief Executive Officer
HBB · Hamilton Beach Brands Holding Co
Effective
2024-02-19
Successor
R. Scott Tidey
Filed
February 22, 2024, 6:59 PM ET
Mr. Trepp, who, prior to the Effective Date, served as President and Chief Executive Officer of the Company, will continue to serve as Chief Executive Officer of the Company after the Effective Date.
Departed

Timothy F. Murphy

Senior Vice President and Chief Financial Officer
ROCK · GIBRALTAR INDUSTRIES, INC.
Filed
February 21, 2024, 6:59 PM ET
On February 18, 2024, Timothy F. Murphy, Senior Vice President and Chief Financial Officer, informed the Company of his plans to retire in early 2025.
Departed

Michael McMullen

President and Chief Executive Officer
A · AGILENT TECHNOLOGIES, INC.
Effective
2024-05-01
Successor
Padraig McDonnell
Filed
February 21, 2024, 6:59 PM ET
Michael McMullen, President and Chief Executive Officer (“CEO”) of Agilent Technologies, Inc. (the “Company” or “Agilent”), notified the Company that he will retire as President and CEO of the Company and as a member of the Company’s Board of Directors (“Board”) on May 1, 2024.
Departed

David Willetts

President and Chief Executive Officer
IEP · ICAHN ENTERPRISES L.P.
Effective
2024-02-21
Successor
Andrew J. Teno
Filed
February 21, 2024, 6:59 PM ET
Mr. Teno will succeed David Willetts, who resigned as President and Chief Executive Officer of the Company and as a member of the Board, effective on the Effective Date.
Appointed

Andrew J. Teno

President and Chief Executive Officer
IEP · ICAHN ENTERPRISES L.P.
Effective
2024-02-21
Filed
February 21, 2024, 6:59 PM ET
On February 21, 2024, the Company announced the appointment of Andrew J. Teno as President and Chief Executive Officer of the Company and of Icahn Enterprises G.P. Inc. (“Icahn Enterprises GP”), the general partner of the Company and Icahn Enterprises Holdings L.P., effective as of February 21, 2024 (the “Effective Date”).
Departed

Glendon E. French

President and Chief Executive Officer
LUNG · Pulmonx Corp
Effective
2024-03-15
Successor
Steven S. Williamson
Filed
February 21, 2024, 6:59 PM ET
On February 20, 2024, Glendon E. French resigned as President and Chief Executive Officer of Pulmonx Corporation (the “Company”), effective as of March 15, 2024

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.